Open Surgical Treatment of Thrombotic Vena Cava Occlusion



Open Surgical Treatment of Thrombotic Vena Cava Occlusion



Nitin Garg and Peter Gloviczki


Thrombotic occlusions of the superior vena cava (SVC) or the inferior vena cava (IVC) requiring open surgical reconstruction are uncommon in the endovascular era. Chronic caval obstruction is usually the result of a previous acute deep vein thrombosis (DVT), which is commonly caused by intravenous central lines or pacemaker wires. It can develop as an extension of a spontaneous DVT from the iliac or subclavian veins, but it can also be caused by mediastinal or retroperitoneal fibrosis; iatrogenic, blunt, or penetrating trauma; congenital venous anomalies and coarctations; and by benign or malignant tumors.



Superior Vena Cava Syndrome


Clinical Presentation


Patients with SVC occlusion come to the hospital with facial or arm swelling, head fullness, dyspnea or orthopnea, generalized headache, or dizziness (Figure 1). The severity of the disease can often be determined by the number of pillows the patient requires to sleep on because of the severe venous engorgement of the head and neck. The most common benign causes today are pacemaker wires, central intravenous lines, and dialysis catheters, although about half of those who undergo open surgical reconstruction have mediastinal fibrosis. These patients in general respond poorly to stenting and have a high rate of recurrent stenosis as a result of the severe calcification around the SVC. Patients who are not candidates for endovascular treatment or in whom previous attempts at thrombolysis or stenting have failed are considered for open surgical reconstruction.




Surgical Technique


Partial or full median sternotomy gains access to the SVC and innominate veins. Spiral saphenous vein graft is the preferred graft material, although panel saphenous vein graft or femoral vein as conduit are also very good choices for autogenous reconstruction. If inflow is good and only a short graft is needed, expanded polytetrafluoroethylene (ePTFE) is an excellent graft material (Figure 2). Cryopreserved or fresh allografts and autogenous or bovine pericardium have also been used with success. Reconstruction of flow from one internal jugular vein is usually all that is required, because collateral circulation of the head and neck is usually excellent. Externally supported ePTFE is used to avoid external compression of the graft if adequate autogenous conduit is not available or in patients with severe mediastinal fibrosis or a tight mediastinum, Extra-anatomic reconstruction using a jugular–femoral bypass with composite saphenous veins has occasionally been used in cancer patients or in others with high risk for median sternotomy.


image
FIGURE 2 A, Left innominate vein–superior vena cava bypass using an externally supported polytetrafluoroethylene (PTFE) graft for the patient with preoperative images in Figure 1. B, Postoperative computed tomographic reconstruction of the patent bypass graft. The patient had an excellent clinical outcome.


Results


In the Mayo Clinic series, 42 patients underwent open surgical SVC reconstruction for benign disease. Spiral saphenous vein graft (SSVG) was used in 22 patients (52%), ePTFE in 13 (31%), femoral vein in six (14%), and allograft in one (2%). The mean pressure gradient across the SVC occlusion was 21 mm Hg (range, 9–43 mm Hg) before reconstruction and 6 mm Hg (range, 0–13 mm Hg) after the reconstruction.


There were no in-hospital or early postoperative deaths. Eight patients (19%) had perioperative nonfatal complications, including one pulmonary embolism. In six patients (14%), early graft thrombosis was successfully revised. The 30-day secondary patency was 100%. Mean follow-up with imaging studies was 3.4 years (range, 1 day to 17.4 years). During follow-up, 11 patients required 18 reinterventions (percutaneous transluminal angioplasty, 10; stenting 7, thrombolysis 1). No complications or deaths were related to secondary interventions. Five-year secondary patency rate of all grafts was 75% (95% confidence interval [CI], 57%–94%) and of the allograft and all veins grafts was 81% (95% CI, 63%–100%). Patency was higher in vein grafts than in ePTFE grafts (p = .05). In the Mayo Clinic study, 93% of patients had significant relief from symptoms.



Inferior Vena Cava Thrombosis


Clinical Presentation


Patients with IVC occlusion at any level can come to the hospital with lower extremity swelling, venous claudication, and advanced chronic venous insufficiency of the legs. Interestingly, many patients with isolated IVC occlusion remain asymptomatic or have mild symptoms until an episode of acute iliocaval DVT. Patients with suprahepatic inferior vena cava occlusion often come to the hospital with BuddChiari syndrome and portal hypertension, and those with suprarenal thrombosis can have renal insufficiency or kidney failure.


Patients with venous claudication, severe swelling, and nonhealing or recurrent ulcers not responding to conservative treatment are considered for further evaluation for endovascular or open surgical reconstruction. An underlying malignancy must always be excluded.


Computed tomography (CT) and magnetic resonance imaging (MRI) have progressed tremendously since the turn of the century and provide excellent three-dimensional imaging of the venous system using venous phase contrast-enhanced imaging (Figure 3A and B). Both modalities are suitable to identify iliocaval, hepatic, pelvic, renal, or iliac venous obstruction. Contrast venography is routinely performed in patients during endovascular reconstruction, and it is often helpful before open repair (Figure 4A).


Stay updated, free articles. Join our Telegram channel

Aug 25, 2016 | Posted by in CARDIOLOGY | Comments Off on Open Surgical Treatment of Thrombotic Vena Cava Occlusion

Full access? Get Clinical Tree

Get Clinical Tree app for offline access